Baupost Group Portfolio holdings
Baupost Group invests for the long term in companies and other investments it judges to be undervalued, on behalf of families, foundations, endowments and other institutions. Its philosophy puts risk management first. Seth Klarman, its chief executive and portfolio manager, founded it in 1982 with William Poorvu, a Harvard professor, and partners Howard Stevenson, Jordan Baruch and Isaac Auerbach, and the name is an acronym built from the founders' names. Poorvu supplied the first money to manage, which he had raised by selling his share in a local television station, and Seth Klarman's team ran it. Seth Klarman wrote a 1991 book on value investing, Margin of Safety.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$419M |
| 2 |
XPO
XPO
|
+$88.3M |
| 3 |
Liberty Global Class C
LBTYK
|
+$73.1M |
| 4 |
Paramount Global Class B
PARA
|
+$72.2M |
| 5 |
Liberty Global Class A
LBTYA
|
+$65.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene
CELG
|
+$377M |
| 2 |
Pioneer Natural Resources
PXD
|
+$305M |
| 3 |
eBay
EBAY
|
+$193M |
| 4 |
Synchrony
SYF
|
+$169M |
| 5 |
AGN
Allergan plc
AGN
|
+$151M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 28.89% |
| 2 | Healthcare | 22.34% |
| 3 | Technology | 15.28% |
| 4 | Consumer Discretionary | 8.63% |
| 5 | Energy | 8.04% |
Similar funds
Baupost Group's Q2 2019 Portfolio in Review
As of Q2 2019, Baupost Group held 36 positions worth $11B, down 7.2% from $11.9B the previous quarter. Its ten largest holdings account for 70% of the portfolio.
Baupost Group withdrew a net $1.24B in Q2 2019, closing 4 positions and reducing 9 holdings. Its most notable exit was Celgene, an estimated $377M position sold in full.
By sector, the portfolio is most concentrated in Communication Services at 29% of assets, up from 25% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Baupost Group opened a new position in XPO worth $86.7M.
- Baupost Group's largest Q2 2019 buy was XPO: 4,337,091 shares worth $86.7M.
- Baupost Group added most to Bristol-Myers Squibb in Q2 2019, an estimated $419M increase.
- Baupost Group's biggest Q2 2019 reduction was eBay, cutting an estimated $193M.
- Baupost Group fully exited Celgene in Q2 2019, selling an estimated $377M.
- Baupost Group's ten largest holdings make up 70% of its $11B portfolio in Q2 2019.
- Baupost Group opened 1 new position and closed 4 in Q2 2019.
- Baupost Group's portfolio value fell 7.2% quarter-over-quarter to $11B.
Based on Baupost Group's 13F filing for Q2 2019, filed 13 Aug 2019.